Wenger Vieli advised Claret Capital Partners on all Swiss legal aspects in connection with its investment in SIS Medical.
Claret Capital Partners is a European investment manager specializing in growth capital, with a long-standing focus on the technology and life sciences sectors. It supports innovative businesses at key stages of growth and provides flexible financing solutions tailored to companies with international ambitions. The investment in SIS Medical marks a further milestone in Claret Capital Partners’ life sciences portfolio and reflects its continued commitment to supporting MedTech innovators.
SIS Medical is a Swiss MedTech company focused on the development, manufacturing and global distribution of innovative cardiovascular products. The investment will support SIS Medical in scaling its operations, strengthening its innovation pipeline and further expanding its clinical portfolio.
The team included Martin Peyer (Partner, Financial Services), Micha Schilling (Counsel, Financial Services) and Michael Baier (Partner, Corporate/M&A).